UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.
Scientists may have found anti-aging mushrooms that can delay signs of aging, but more research is needed to make eating them feasible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback